This article is more than 5 years old. Information may no longer be current.
Four investigators, mentors receive grants for PAH research
Click Here to Manage Email Alerts
To support their research in pulmonary arterial hypertension, four researchers and their mentors received the Entelligence Young Investigators Award from Actelion Pharmaceuticals US Inc. and the Entelligence Steering Committee on June 4.
Each recipient was granted $100,000 for 1 year of PAH research. The award specifically acknowledges young investigators who have fewer than 5 years of experience beyond a first faculty appointment.
The winners and their research topics are:
- Harry Karmouty-Quintana, PhD, assistant professor at the University of Texas-Health Science Center at Houston, mentored by Michael R. Blackburn, PhD; conducting research on the role of hyaluronan in pulmonary hypertension associated with idiopathic pulmonary fibrosis
- Michael L. O’Byrne, MD, fellow physician in the Division of Cardiology at the Children’s Hospital of Philadelphia, mentored by Jonathan J. Rome, MD; conducting research on cardiac catheterization in children with PAH
- Tien Peng, MD, instructor in the Pulmonary, Allergy and Critical Care Division at the Hospital of the University of Pennsylvania, mentored by Edward Morrisey, PhD; conducting research on the role of sonic hedgehog signaling in PAH
- Keivan Zandinejad, MD, pulmonary/critical care and sleep fellow at Case Western Reserve University, mentored by Jonathan S. Stamler, MD; conducting research on S-nitroslyation therapy in the treatment of hypoxia-induced PAH.
The Entelligence program, which began in 2005, supports research to improve treatment options for patients with PAH and is funded through an independent grant from Actelion Pharmaceuticals.
“For the past 8 award cycles, Entelligence, with nearly $3.5 million in funding, has supported innovative basic, translational, and clinical research that has fostered the development of 42 young investigators’ careers in pulmonary vascular research,” Ronald J. Oudiz, MD, Entelligence Steering Committee chairman and director of the Liu Center for Pulmonary Hypertension at the LA Biomedical Research Institute at Harbor-UCLA Medical Center, said in a press release.
“I am extremely proud of the accomplishments of the Entelligence Young Investigators Program.”